Estrogen enhances proliferative capacity of cardiac fibroblasts by estrogen receptor and mitogen activated protein kinase dependent pathways

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 7, 1998, Pages 1359-1368

  Lee, Hyeon Woo ^a   Eghbali Webb, Mahboubeh ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Gender; Heart; Hypertrophy; MAP kinase; Mitogen; Receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CELL DNA; ESTRADIOL; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN BASIC PROTEIN; TAMOXIFEN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032128427     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0699     Document Type: Article

References (40)

1. 1, thyroid hormone, angiotensin II and basic fibroblast growth factor. J Mol Cell Cardiol 29: 2233-2244.
2. ARONICA SM, KRAUS WL, KATZENELLENBOGEN BS, 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci 91: 8517-8521.
3. BUNONE G, BRIAND PA, MIKSICEK RJ, PICARD D, 1996. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J
4. CAPASSO JM, REMILY RM, SMITH RH, SONNENBLICK EH, 1983. Sex-related differences in myocardial contractility in the rat. Basic Res Cardiol 78: 156-171.
5. CHUANG CF, NG SY, 1994. Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors. FEBS Lett 346: 229-234.
6. COBB MH, HELPER JE, CHENG M, ROBBINS D, 1994. The mitogen-activated protein kinases, ERK1 and ERK2. Sem Cancer Biol 5: 261-268.
7. CREUZZET C, LOEB J, BARBIN G, 1995. Fibroblast growth factors stimulate tyrosine phosphorylation and mitogen-activated protein kinase activity in primary cultures of hippocampal neurons. J Neurochem 64: 1541-1547.
8. DI DOMENICO M, CASTORIA G, BILANCIO A, MIGLIACCIO A, AURICCHIO F, 1996. Estradiol activation of human colon carcinoma-derived Cao-2 cell growth. Canc Res 56: 4516-4521.
9. DROUVA SV, GORENNE I, LAPLANTE E, RERAT E, ENJALBERT A, KORDON C, 1990. Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vivo. Endocrinology 126: 536-544.
10. DUDLEY D, PANG L, DECKER SJ, BRIDGES A, SALTIEL AR, 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci 92: 7686-7689.
11. 1 in the normal rat myocardium. Cell Tiss Res 256: 553-558.
12. EGHBALI M, CZAJA MJ, ZEYDEL M, WEINER FR, ZERN MA, SEIFTER S, BLUMENFELD OO, 1988. Collagen mRNAs in isolated adult heart cells. J Mol Cell Cardiol 20: 267-276.
13. 1 and phorbol myristate acetate on cardiac flbroblasts: regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 69: 483-490.
14. EGHBALI ME, EGHBALI M, ROBINSON TF, SEIFTER S, BLUMENFELD OO, 1989. Collagen accumulation in heart ventricles as a function of growth and aging. Cardiovasc Res 23: 723-729.
15. 2+ uptake. Circ Res 81: 242-248.
16. JOHNSON GL, VAILLANCOURT RR, 1994. Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 6: 230-238.
17. KARIN M, HUNTER T, 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 5: 747-757.
18. KLOCH W, HEIDECKER G, LLOYD P, RAPP UR, 1991. Raf-1 protein kinase is required for growth of induced NIH/ 3T3 cells. Nature 349: 426-428.
19. KUIPER GGJM, ENMARK E, PELTO-HUIKKO M, NILSSON S, GUSTAFSSON J-A, 1996. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci 93: 5925-5930.
20. KUIPER GGJM, CARLSON B, GRANDIEN K, ENMARK E, HAGGBLAD J, NILSSON S, GUSTAFSSON J-A, 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and B. Endocrinology 138: 863-870.
21. LIAO DF, MONIA B, DEAN N, BERK BC, 1997. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Cell Biol 272: 6146-6150.
22. LONG CS, HENRICH CJ, SIMPSON PC, 1991. A growth factor for cardiac myocytes is produced by cardiac non-myocytes. Cell Regulation 2: 1081-1095.
23. Lou H, ZHAO Y, DE LA FONTAINE P, KODAMA T, KATZ N, RAMWELL PW, FOEGH ML, 1997. Estrogen effects on insulin-like growth factor-1 (IGF-1)-induced cell proliferation and IGF-1 expression in native and allograft vessels. Circulation 96: 927-933.
24. MALHOTRA A, BUTTRICK P, SCHEUER J, 1990. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 259: H866-H871.
25. MIGLIACCIO A, DI DOMENICO M, CASTORIA G, DE FALCO A, BONTEMPO P, NOLA E, AURICCHIO F, 1996. Tyrosine kinase/p21ras/Map-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292-1300.
26. MINDEN A, LIN A, MCMAHON M, LANGE-CARTER CA, DERIJARD B, DAVIS RJ, JOHNSON GL, KARIN M, 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723.
27. MORLEY P, WHITFIELD JF, VANDERHYDEN BC, TSANG BK, SCHWARTZ JL, 1992. A new non-genomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131: 1305-1312.
28. MOSSELMAN S, POLMAN J, DIJKEMA R, 1996. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49-53.
29. ORITA H, FUKASAWA M, HIROOKA S, UCHINO H, FUKUI K, WASHIO M, 1993a. Modulation of cardiac myocyte beating rate and hypertrophy by cardiac fibroblasts isolated from neonatal rat ventricle. Jap Circ J (English Ed) 57: 912-920.
30. ORITA H, FUKASAWA M, HIROOKA S, FUKUI K, KOHI M, WASHIO M, SASAKI H, 1993b. Protection of cardiac myocytes from hypothermic injury by cardiac fibroblasts isolated from neonatal rat ventricle. J Surg Res 55: 654-658.
31. mapk are required for fibroblast proliferation. Proc Natl Acad Sci 90: 8319-8323.
32. PFEIFFER DG, MACLUSKY NJ, BARNEA E, NAETOLIN F, KREY LC, LORIAUX DL, MERRIAM GR, 1986. Are oestrogens obligatory mediators of oestrogen action in the central nervous system? I. Characterization of pharmacological probes with different receptor binding affinities and catechol oestrogen formation rates. J Endocrinol 11: 489-497.
33. SADOSHIMA J, JAHN L, TAKAHASHI T, KULIK TJ, IZUMO S, 1992. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vivo model of load-induced cardiac hypertrophy. J Biol Chem 267: 10551-10560.
34. SAUMA S, FRIEDMAN E, 1996. Increased expression of protein kinase Cβ activates ERK3. J Biol Chem 271: 11422-11426.
35. SCHORB W, BOOZ GW, DOSTAL DE, CONRAD KM, CHANG KC, BAKER KM, 1993. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245-1254.
36. SCHRAMEK H, SCHUMACHER M, WILFLINGSEDER D, OBERLEITHNER H, PEALLER W, 1997. Differential expression and activation of MAP kinases in dedifferentiated MDCK focus cells. Am J Physiol 272: C383-391.
37. 1. J Mol Cell Cardiol 28: 1921-1929.
38. SIMM A, NESTLER M, HOPPE V, 1997. PDGF-AA, a potent mitogen for cardiac fibroblasts from adult rats. J Mol Cell Cardiol 29: 357-368.
39. TREMBLAY GB, TREMBLAY A, COPELAND NG, GILBERT DJ, JENKINS NA, LABRIE F, GIGUERE V, 1997. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11: 353-365.
40. WOLINSKY H, 1971. Effects of hypertension and its reversal on the thoracic aorta of male and female rats. Circ Res 28: 622-637.